Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
Trastuzumab treatment does not prevent intracranial seeding and is largely ineffective for established central nervous system metastasis in HER2 overexpressing breast cancer patients. Combination therapy of lapatinib and capecitabine may be an effective treatment option for brain metastasis of HER2-...
Saved in:
Main Authors: | Esin Oktay, Özlem Yersal, Nezih Meydan, Mehmet Sağıroğlu, Ömer Uyanık, Sabri Barutca |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/234391 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
by: Özlem Yersal, et al.
Published: (2018-01-01) -
Outcomes of Treatment for Melanoma Brain Metastases
by: Mantas Janavicius, et al.
Published: (2020-01-01) -
Ileitis Secondary to Oral Capecitabine Treatment?
by: Rami Radwan, et al.
Published: (2012-01-01) -
Advanced Mesodermal (Müllerian) Adenosarcoma of the Ovary: Metastases to the Lungs, Mouth, and Brain
by: A. Daskalaki, et al.
Published: (2015-01-01) -
A Rare Occurrence of Isolated Brain Metastases from Gastric Cancer
by: Manish M. Karamchandani, et al.
Published: (2019-01-01)